Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 31, 2011 CLMS, NBIX, GFF, ACLS, LPSN, PZZA Expected To Be Down Before Next Earnings Releases
January 31, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and February earnings reports. CALAMOS ASSET MANAGEMENT-A (NASDAQ:CLMS), NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX), GRIFFON CORPORATION (NYSE:GFF), AXCELIS TECHNOLOGIES INC (NASDAQ:ACLS), LIVEPERSON INC (NASDAQ:LPSN), PAPA JOHN'S INTL INC (NASDAQ:PZZA) are all expected to be Down Before their earnings are released . The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released :
Symbol Company # of Reports Quarter Release Date
CLMS CALAMOS ASSET MANAGEMENT-A 6 Quarter Q4 02/03/2011
NBIX NEUROCRINE BIOSCIENCES INC 12 Quarter Q4 02/03/2011
GFF GRIFFON CORPORATION 12 Quarter Q1 02/03/2011
ACLS AXCELIS TECHNOLOGIES INC 12 Quarter Q4 02/01/2011
LPSN LIVEPERSON INC 6 Quarter Q4 02/10/2011
PZZA PAPA JOHN'S INTL INC 6 Quarter Q4 02/22/2011
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
CALAMOS ASSET MANAGEMENT-A (NASDAQ:CLMS) - Calamos Asset Management Inc. is a publicly owned investment manager. The firm provides investment advisory services to individuals including high net worth individuals, and institutions. It also manages accounts for family offices and private foundations. The firm manages separate client-focused open-end and closed-end for its clients. It also offers separately managed accounts to its clients. The firms investment process spreads across a range of investment strategies within the equity, global/international, balanced, high yield, convertible, and alternative investment classes. It invests in the public equity and fixed income markets across the globe. The firm primarily invests in growth and value stocks of companies. It also functions as a boutique investment firm. The firm employs qualitative and fundamental analysis with a top-down and bottom-up stock picking approach to make its investments. Calamos Asset Management was founded in 1977 and is based in Naperville, Illinois.
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) - Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine-related diseases and disorders. Its products in clinical development include Elagolix, a phase II product for endometriosis; CRF1 Antagonist, a phase II product for mood disorders; CRF2 Peptide Agonist, a phase II drug for cardiovascular diseases; CRF1 Antagonist, a phase I product for treating mood disorders and irritable bowel syndrome; Vesicular Monoamine Transporter 2 Inhibitor, a phase I product for movement disorders and schizophrenia; and Elagolix, a phase I product for uterine fibroids, and mens and womens health. The companys research programs comprise Glucose Dependent Insulin Secretagogues for type II diabetes; Antiepileptic Drugs for epilepsy and bipolar disorder; and GnRH Antagonists for hormone dependent diseases and oncology. Its product pipeline also includes Indiplon 5mg and 10mg capsules, the FDA deemed approvable products, for the treatment of insomnia. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott Laboratories to develop and commercialize elagolix for the treatment of endometriosis-related pain; and Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
GRIFFON CORPORATION (NYSE:GFF) - Griffon Corporation, through its subsidiaries, operates as a manufacturing company. The company operates through three segments: Telephonics, Building Products, and Plastics. The Telephonics segment specializes in advanced electronic information and communication systems for defense, aerospace, civil, industrial, and commercial applications. This segment designs, manufactures, sells, and provides logistical support for aircraft communication systems, radar, air traffic management, information and command and control systems, identification friend or foe equipment, integrated homeland security systems, and application specific integrated circuits. This segment also supplies airborne maritime surveillance radar and aircraft intercommunication management systems. The Building Products segment manufactures and markets garage doors and sectional doors for home remodeling, new residential housing, and commercial building markets under the Clopay, Ideal Door, and Holmes brand names. The Plastics segment develops and produces specialty plastic films and laminates, including thin gauge embossed and printed films, elastomeric films, and laminates of film and non-woven fabrics, which are used as moisture barriers in disposable infant diapers, adult incontinence products, and feminine hygiene products; as protective barriers in single-use surgical and industrial gowns, drapes, and equipment covers; and as packaging for hygienic products, house wrap, and other products. Griffon Corporation sells its products through direct sales force and sales representatives, as well as through installing dealers, retailers, and wholesalers. The company operates primarily in the United States, Germany, Canada, Brazil, and the United Kingdom. Griffon Corporation was founded in 1959 and is headquartered in New York, New York.
AXCELIS TECHNOLOGIES INC (NASDAQ:ACLS) - Axcelis Technologies, Inc. designs, manufactures, and services ion implantation, dry strip, and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. Its products include a line of high energy, high current, and medium current ion implanters for various applications; and a line of single wafer implanters, known as the Optima platform, comprising the Optima HD, the Optima XE, and the Optima MD. The company also offers dry strip tools, including the Integra RS, which comprises paired-chamber process modules. In addition, it provides aftermarket services and support, including spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services through direct sales force, distributors, and manufacturing representatives. Axcelis Technologies was founded in 1995 and is headquartered in Beverly, Massachusetts.
LIVEPERSON INC (NASDAQ:LPSN) - LivePerson, Inc. provides online engagement solutions that facilitate real-time assistance and advice. It connects businesses and independent service providers with consumers seeking help on its hosted software platform. The companys hosted platform supports and manages real time online interactions, such as chat, voice/click-to-call, email, and self service/knowledgebase from a single agent desktop. The company offers LivePerson Enterprise for Sales solution that combines online site traffic monitoring software with a rules engine to enable its clients to proactively engage Web site visitors; and LivePerson Enterprise for Service solution, which enhances its contact center by identifying customers who are struggling with their self help experience, and connecting them to a live customer care specialist. It also offers LivePerson Premier that helps businesses in visitor engagement and provides insights into online sales initiatives and customer care issues; LivePerson Pro that enables chat agents to segment visitors based on various attributes, and target the candidates for a chat in real time; and Multichannel Contact Center Solutions, which help businesses to add LivePersons voice, email, and knowledgebase channels to LivePerson Pro or LivePerson Premier. In addition, the company provides professional services and value added business consulting services. LivePerson, Inc. sells its products and services through direct and indirect sales channels to financial, retail, telecommunications, technology, and travel/hospitality industries, as well as to small and mid-sized businesses, Internet businesses, online merchants, universities, libraries, government agencies, and not-for-profit organizations in the United States, Canada, Israel, and Europe. The company was founded in 1995 and is headquartered in New York, New York.
PAPA JOHN'S INTL INC (NASDAQ:PZZA) - Papa Johns International, Inc. operates and franchises pizza delivery and carryout restaurants under the trademark Papa Johns in the United States. The company also operates dine-in and restaurant-based delivery restaurants in certain international markets. As of December 27, 2009, it operated 3,469 Papa Johns restaurants consisting of 614 company-owned and 2,855 franchised restaurants in 50 states, the District of Columbia, and Puerto Rico, as well as in 29 countries. The company was founded in 1985 and is based in Louisville, Kentucky.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
- WOPRAI
- support@woprai.com